CIDRAP newsletters options
Babies exposed to COVID in-utero had triple the risk, but it wasn't as high when moms were vaccinated.
The CRISPR-engineered bacteriophage therapy from Locus Biosciences targets urinary tract infections caused by drug-resistant E coli.
Lack of human resources, absence of leadership, and limited microbiology laboratory support are some of the issues cited.
Senators said they're hopeful about vaccine development, but worry that trade agreements aren't keeping pace with scientific progress.
At 90-days post-infection, 8% of vaccinated cases were still reporting symptoms, compared with 27% of unvaccinated cases.
Both sperm concentration and total sperm number were significantly lower 3 months after infections.
The six studies that examined all-cause death and the 13 on diabetes-related death showed consistent increases in both.
The findings could help inform real-time guidance, as ongoing scientific study continues.
Discordant findings on Paxlovid and long COVID illustrate why more trials are needed.
Investigators say the strategy is readily applicable in low- and middle-income countries, where high rates of ventilator-associated pneumonia drive antibiotic use.
Reduced antibiotic consumption was related to de-escalation and discontinuation of empiric antibiotic therapy during the intervention period.
Over the course of the study period, average daily use of three electronic message systems increased.
Officials recently warned that Europe's measles cases rose more than 30-fold in 2023.
Non-exclusive licensing of the yeast strain by developers will allow others to develop effective, low-cost vaccines.
Experts say the updated definition and new scoring system is better at identifying children with sepsis and has the potential to improve care and outcomes.
Wastewater estimates suggest that clinical cases underestimate the true burden by a factor of 2- to 19-fold.
The highest absolute risk of disabilities among adult meningitis survivors was for behavioral and emotional disorders, hearing loss, and impaired vision.
Most errors didn't result in an adverse event, and the few that did were recorded as nonserious.
The first patients to receive the vaccine were a pair of twin babies.
Early tecovirimat was associated with shorter time to symptom improvement (by 5.5 days) among participants with severe illness.
